The once-daily pill, currently under investigation, is being studied for adults with type 2 diabetes who are not on any ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

Come summer, and everyone craves mangoes. However, the fruit walks a tightrope for those who love it but have diabetes.

A new study, published in the journal PLOS Medicine, revealed that the combination of certain food additives can lead to an increased risk of dangerous health conditions, like type 2 diabetes.

Certain additives found in ultra-processed foods are linked to increased type 2 diabetes risk, a new study finds. The mixtures are typically present in broths, dairy desserts, fats, sauces, and sugary ...

Eli Lilly has seen positive results from a phase 3 trial of Orforglipron, the first-ever GLP-1 pill for weight loss and type ...

Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...

Living with diabetes doesn’t mean you can’t enjoy Easter treats and traditions. You might try food swaps or alternatives with ...

People diagnosed with type 2 diabetes might benefit soon from Eli Lilly's new orforglipron weight loss drug following its ...

A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

A new study found that certain combinations of food additives are linked to a higher chance of developing type 2 diabetes. Experts discuss how to mitigate risk.